Abstract
Saw palmetto extract (SPE) has been widely used for the treatment of lower urinary-tract symptoms secondary to benign prostatic hyperplasia. The mechanisms of pharmacological effects of SPE include the inhibition of 5a-reductase, anti-androgenic effects, anti-proliferative effects, and anti-inflammatory effects. Previously, we showed that SPE bound actively to a1-adrenergic, muscarinic and 1,4-dihydropyridine calcium channel (1,4-DHP) receptors in the prostate and bladder of rats, whereas its active constituents have not been fully clarified. The present investigation is aimed to identify the main active components contained in hexane and diethyl ether extracts of SPE with the use of column chromatography and preparative HPLC. Based on the binding activity with a1-adrenergic, muscarinic, and 1,4-DHP receptors, both isolated oleic and lauric acids were deduced to be active components. Authentic samples of oleic and lauric acids also exhibited similar binding activities to these receptors as the fatty acids isolated from SPE, consistent with our findings. In addition, oleic and lauric acids inhibited 5α-reductase, possibly leading to therapeutic effects against benign prostatic hyperplasia and related lower urinary-tract symptoms.
Similar content being viewed by others
References
R. M. Levin and A. K. Das, Urol. Res., 2000, 28, 201.
H. Lepor, W. O. Williford, M. J. Barry, M. K. Brawer, C. M. Dixon, G. Gormley, C. Haakenson, M. Machi, P. Narayan, and R. J. Padley, N. Engl. J. Med., 1996, 335, 533.
T. J. Wilt, A. Ishani, G. Stark, R. MacDonald, J. Lau, and C. Mulrow, J. A. M. A., 1998, 280, 1604.
M. Suzuki, Y. Ito, T. Fujino, M. Abe, K. Umegaki, S. Onoue, H. Noguchi, and S. Yamada, Acta Pharmacol. Sin., 2009, 30, 27.
C. Iehlé, S. Délos, O. Guirou, R. Tate, J. P. Raynaud, and P. M. Martin, J. Steroid Biochem. Mol. Biol., 1995, 54, 273.
T. Liang and S. Liao, Biochem. J., 1992, 285, 557.
M. Goepel, U. Hecker, S. Krege, H. Rübben, and M. C. Michel, Prostate, 1999, 38, 208.
C. Sultan, A. Terraza, C. Devillier, E. Carilla, M. Briley, C. Loire, and B. Descomps, J. Steroid Biochem., 1984, 20, 515.
L. S. Adams, N. P. Seeram, M. L. Hardy, C. Carpenter, and D. Heber, Evid. Based Complement. Alternat. Med., 2006, 3, 117.
W. Breu, M. Hagenlocher, K. Redl, G. Tittel, F. Stadler, and H. Wagner, Arzneim. Forsch., 1992, 42, 547.
T. Oki, M. Suzuki, Y. Nishioka, A. Yasuda, K. Umegaki, and S. Yamada, J. Urol., 2005, 173, 1395.
M. Suzuki, T. Oki, T. Sugiyama, K. Umegaki, S. Uchida, and S. Yamada, Urol., 2007, 69, 1216.
T. Oki-Fujino, M. Suzuki, and S. Yamada, Jpn. J.complement Altern. Med., 2007, 4, 41.
F. J. Ehlert and L. P. Tran, J. Pharmacol. Exp. Ther., 1990, 255, 1148.
S. Yamada, N. Ashizawa, H. Ushijima, K. Nakayama, E. Hayashi, and K. Honda, J. Pharmacol. Exp. Ther., 1987, 242, 326.
S. Yamada, R. Kimura, Y. Harada, and K. Nakayama, J. Pharmacol. Exp. Ther., 1990, 252, 327.
K. Mitamura, C. Ogasawara, A. Shiozawa, E. Terayama, and K. Shimada, Anal. Sci., 2005, 21, 1241.
J. Liu, K. Kurashiki, K. Shimizu, and R. Kondo, Biol. Pharm. Bull., 2006, 29, 392.
M. M. Bradford, Anal. Biochem., 1976, 72, 248.
H. Weisser, S. Tunn, B. Behnke, and M. Krieg, Prostate, 1996, 28, 300.
E. Neuzil and H. Cousse, Bull. Soc. Pharm. Bordeaux, 1993, 132, 121.
H. J. Niederprüm, H. U. Schweikert, and K. S. Zanker, Phytomedicine, 1994, 1, 127.
M. J. Barry, J. A. M. A., 1997, 278, 2178.
J. P. Raynaud, H. Cousse, and P. M. Martin, J. Steroid Biochem. Mol. Biol., 2002, 82, 233.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abe, M., Ito, Y., Suzuki, A. et al. Isolation and Pharmacological Characterization of Fatty Acids from Saw Palmetto Extract. ANAL. SCI. 25, 553–557 (2009). https://doi.org/10.2116/analsci.25.553
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.25.553